Morgan Stanley
DERM icon

Morgan Stanley’s Journey Medical DERM Stock Holding History

Morgan Stanley’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$298K Buy
42,024
+31,489
+299% +$180K ﹤0.01% 5778
2026
Q1 		$49.4K Sell
10,535
-15,965
-60% -$124K ﹤0.01% 6427
2025
Q4 		$204K Buy
26,500
+5,768
+28% +$45.2K ﹤0.01% 5922
2025
Q3 		$148K Sell
20,732
-31,182
-60% -$226K ﹤0.01% 6003
2025
Q2 		$373K Buy
51,914
+37,721
+266% +$261K ﹤0.01% 5597
2025
Q1 		$83.7K Buy
14,193
+4,493
+46% +$22.1K ﹤0.01% 6095
2024
Q4 		$37.9K Buy
+9,700
New +$53K ﹤0.01% 6375
2024
Q2 		– Sell
-550
Closed -$2.02K – 7869
2024
Q1 		$2.02K Buy
550
+350
+175% +$1.52K ﹤0.01% 7070
2023
Q4 		$1.15K Buy
+200
New +$891 ﹤0.01% 7120

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAIM
Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Morgan Stanley's DERM Position: Q2 2026 in Review

Morgan Stanley increased its Journey Medical (DERM) stake by 299% in Q2 2026, buying an estimated $180K and bringing the position to 42,024 shares worth $298K. The position accounts for ﹤0.01% of the portfolio, ranked #5778.

Morgan Stanley first reported a position in DERM in Q4 2023 and has held it in 9 quarters since. The position peaked at $373K in Q2 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

  • Morgan Stanley held 42,024 shares of Journey Medical worth $298K as of Q2 2026.
  • Morgan Stanley bought 31,489 Journey Medical shares in Q2 2026, an estimated $180K.
  • Journey Medical made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #5778 holding.
  • Morgan Stanley first reported a position in Journey Medical in Q4 2023 and has held it in 9 quarters since.
  • Morgan Stanley's Journey Medical position peaked at $373K in Q2 2025.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.